Código QR

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by an abnormal clonal proliferation of malignant plasma cells. Despite the introduction of novel agents that have significantly improved clinical outcome, most patients relapse and develop drug resistance. MM is characterized by genom...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Angélique Bruyer, Laure Dutrieux, Hugues de Boussac, Thibaut Martin, Djamila Chemlal, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Laure Vincent, Charles Herbaux, Malik Lutzmann, Caroline Bret, Philippe Pasero, Jérôme Moreaux, Sara Ovejero
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Assuntos:
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fonc.2023.1271847/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!